Skip to main content
BIOCRYST PHARMACEUTICALS INC logo

BIOCRYST PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · BCRX ISIN · US09058V1035 LEI · 549300Z0INP1Z5NP6J59 US Manufacturing
Filings indexed 1,409 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country US United States of America
Listing US BCRX

About BIOCRYST PHARMACEUTICALS INC

https://www.biocryst.com/

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company dedicated to discovering, developing, and commercializing novel medicines for patients with rare and serious diseases. The company's primary focus is on hereditary angioedema (HAE), alongside other rare conditions. BioCryst utilizes its expertise in structure-guided drug design, a process that integrates advanced technologies with biology and medicinal chemistry, to create innovative therapies. It specializes in developing first-in-class or best-in-class oral small-molecule and protein therapeutics, aiming to provide more convenient and effective treatment options for patients.

Recent filings

Filing Released Lang Actions
8-K - BIOCRYST PHARMACEUTICALS INC (0000882796) (Filer)
Regulatory Filings
2026-05-04 English
DEF 14A - BIOCRYST PHARMACEUTICALS INC (0000882796) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English
SCHEDULE 13G/A - BIOCRYST PHARMACEUTICALS INC (0000882796) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Issuer)
Director's Dealing
2026-03-24 English
144 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Subject)
Regulatory Filings
2026-03-20 English
4 - BIOCRYST PHARMACEUTICALS INC (0000882796) (Filer)
Director's Dealing
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.